PRTN3 and anti-neutrophil cytoplasmic antibody-associated vasculitis: Finally, PR3-ANCA positivity and azathioprine arm were independently associated with a higher risk of relapse in a trial comparing rituximab with azathioprine to maintain remission in 115 patients with AAV.37